𝗖𝗮𝘁𝘁𝗲𝗿𝗶𝗰𝗸 𝗖𝗼𝗻𝘀𝘂𝗹𝘁𝗶𝗻𝗴 provides independent, executive-level, strategic advice in pharmaceutical market access, working directly with biotech and pharmaceutical leadership teams and in partnership with specialist consultancies and agencies. Our focus is to shape access strategy, de-risk high-stakes decisions and deliver sustainable patient access across the full product lifecycle.

Founded by 𝗗𝗮𝘃𝗶𝗱 and 𝗡𝗶𝗰𝗸𝗶, both recognised market access leaders with a combined 45 years’ experience across the NHS and pharmaceutical market access, commercial and R&D functions, the consultancy brings deep credibility at Global, National and Local levels. 

With their breadth of experience 𝗗𝗮𝘃𝗶𝗱 and 𝗡𝗶𝗰𝗸𝗶 therefore bring a unique perspective and deep, informed, insight into market access challenges and opportunities.

𝗖𝗮𝘁𝘁𝗲𝗿𝗶𝗰𝗸 𝗖𝗼𝗻𝘀𝘂𝗹𝘁𝗶𝗻𝗴 is engaged when the decisions matter most - early asset and portfolio strategy, complex or reputationally sensitive HTAs, launch sequencing, commercial negotiation, post-launch uptake challenges, and access policy change. We provide senior-level challenge and clarity, grounded in a pragmatic, experienced, understanding of how Global, National and Local healthcare systems respond in the real world.

This is not a traditional agency model. Our role is not to replace execution teams, but to develop and strengthen strategy, reduce uncertainty, improve decision quality. Clients work directly with a senior advisor who focuses on the critical strategic choices that determine access success - before they become costly problems.

We do this by working directly with companies and alongside established consultancies to complement their technical excellence and delivery capability with executive level strategic judgement, healthcare system realism and portfolio-level perspective. This ensures access strategies are clear and executable, evidence is prioritised, risk is understood, and leadership is aligned.

Catterick Consulting Ltd

Org chart

Teams

Offices